GlassScriptPhysician profile
Luke A Cusimano
NPI 1396062030
$1,132.39
in general payments reported to CMS, 2019-2025
16 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.24 · 2020: $71.95 · 2021: $149 · 2022: $12.14 · 2023: $198 · 2024: $256 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.35 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $462.01 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Revance Therapeutics, INC. | $138.78 | 2025 | Daxi |
| Baxter Healthcare | $101.24 | 2020-2025 | |
| Allergan, INC. | $78.48 | 2019-2021 | |
| Tela Bio, INC. | $54.22 | 2019-2024 | Ovitex 2s |
| Pacira Pharmaceuticals Incorporated | $46.42 | 2022-2025 | Exparel |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Bard Peripheral Vascular, INC. | $39.06 | 2021 | |
| Mentor Worldwide LLC | $30.67 | 2021 | |
| Motiva USA, LLC | $26.75 | 2025 | |
| Kerecis Limited | $25.80 | 2021 | |
| Heron Therapeutics, INC. | $24.39 | 2025 | Zynrelef |
| Kci USA, INC. | $18.58 | 2020 | |
| Smith+Nephew, INC. | $17.83 | 2021 | |
| Integra Lifesciences Corporation | $13.80 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Cusimano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.